R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Read More…
Industry, Sector and Symbol
Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Phone312-324-7820
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$868.50 million
Profitability
Miscellaneous
Employees18,600
Next Earnings Date8/8/2019 (Estimated)
OptionableNot Optionable
R1 RCM (NASDAQ:RCM) Frequently Asked Questions
What is R1 RCM's stock symbol?
R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
How were R1 RCM's earnings last quarter?
R1 RCM Inc (NASDAQ:RCM) announced its earnings results on Thursday, May, 9th. The financial services provider reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.01. The financial services provider had revenue of $275.90 million for the quarter, compared to analyst estimates of $266.37 million. R1 RCM had a negative net margin of 2.19% and a negative return on equity of 118.28%. The company's revenue for the quarter was up 87.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.26) EPS. View R1 RCM's Earnings History.
When is R1 RCM's next earnings date?
What guidance has R1 RCM issued on next quarter's earnings?
R1 RCM updated its FY 2019 earnings guidance on Thursday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.15-1.25 billion, compared to the consensus revenue estimate of $1.2 billion.
What price target have analysts set for RCM?
4 brokers have issued 12 month target prices for R1 RCM's stock. Their forecasts range from $10.00 to $20.00. On average, they expect R1 RCM's stock price to reach $15.00 in the next year. This suggests a possible upside of 29.3% from the stock's current price. View Analyst Price Targets for R1 RCM.
What is the consensus analysts' recommendation for R1 RCM?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.
What are Wall Street analysts saying about R1 RCM stock?
Here are some recent quotes from research analysts about R1 RCM stock:
- 1. According to Zacks Investment Research, "R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is headquartered in Chicago, Illinois. " (6/8/2019)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on RCM shares and maintain our 12-mo. PT of $13. We recently attended a comprehensive webinar hosted by R1 RCM, titled Intelligent Driving a New Level of Revenue Cycle Performance". During the session, we were provided a background on automation followed by a more detailed view into how R1 is using automation to drive performance for its provider clients. We continue to believe there is significant opportunity for automation to generate value for providers. R1 has an impressive digital offering, which we believe provides a competitive edge. We believe these efforts should drive solid top-line growth and margin expansion long term." (4/12/2019)
Has R1 RCM been receiving favorable news coverage?
Headlines about RCM stock have trended somewhat negative on Saturday, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. R1 RCM earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for R1 RCM.
Who are some of R1 RCM's key competitors?
What other stocks do shareholders of R1 RCM own?
Who are R1 RCM's key executives?
R1 RCM's management team includes the folowing people:
- Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
- Mr. Christopher Simon Ricaurte, CFO & Treasurer (Age 59)
- Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
- Mr. Richard B. Evans Jr., Principal Accounting Officer, Sr. VP & Corp. Controller (Age 51)
- Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
Who are R1 RCM's major shareholders?
R1 RCM's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.90%), Wellington Management Group LLP (5.35%), Paradigm Capital Management Inc. NY (5.06%), SCW Capital Management LP (3.29%), Litespeed Management L.L.C. (2.38%) and Renaissance Technologies LLC (2.36%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.
Which major investors are selling R1 RCM stock?
RCM stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Litespeed Management L.L.C., Dimensional Fund Advisors LP, BlackRock Inc., Penn Capital Management Co. Inc., Paradigm Capital Management Inc. NY and SCW Capital Management LP. View Insider Buying and Selling for R1 RCM.
Which major investors are buying R1 RCM stock?
RCM stock was purchased by a variety of institutional investors in the last quarter, including Voya Investment Management LLC, Moab Capital Partners LLC, Park West Asset Management LLC, PNC Financial Services Group Inc., 361 Capital LLC, Royce & Associates LP, Goldman Sachs Group Inc. and Insight Wealth Strategies LLC. View Insider Buying and Selling for R1 RCM.
How do I buy shares of R1 RCM?
Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is R1 RCM's stock price today?
One share of RCM stock can currently be purchased for approximately $11.60.
How big of a company is R1 RCM?
R1 RCM has a market capitalization of $1.28 billion and generates $868.50 million in revenue each year. The financial services provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.
What is R1 RCM's official website?
How can I contact R1 RCM?
R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The financial services provider can be reached via phone at 312-324-7820 or via email at [email protected]
MarketBeat Community Rating for R1 RCM (NASDAQ RCM)
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
